Is KTRA or BTI a better dividend investment in 2026?

KTRA currently yields 928.51% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: KTRA offers higher current income.

What is the dividend yield difference between KTRA and BTI?

KTRA has a forward dividend yield of 928.51% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 923.13 percentage points.

Home › Compare › KTRA vs BTI

KTRA vs BTI: Dividend Comparison 2026

KTRA yields 928.51% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KTRA wins by $9.224768444729638e+22M in total portfolio value

INVESTMENT

TIME HORIZON10 years

KTRA

● Live price

928.51%

Share price

$0.22

Annual div

$2.00

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$9.224768444729638e+22M

Annual income

$92,228,602,655,528,430,000,000,000,000.00

Full KTRA calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — KTRA vs BTI

📍 KTRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KTRA	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KTRA + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KTRA pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KTRA

Annual income on $10K today (after 15% tax)

$78,922.93/yr

After 10yr DRIP, annual income (after tax)

$78,394,312,257,199,170,000,000,000,000.00/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, KTRA beats the other by $78,394,312,257,199,170,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KTRA + BTI for your $10,000?

KTRA: 50%BTI: 50%

100% BTI50/50100% KTRA

Portfolio after 10yr

$4.612384222364819e+22M

Annual income

$46,114,301,327,764,220,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

KTRA

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-7.7

Piotroski

1/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KTRA buys

BTI buys

No recent congressional trades found for KTRA or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKTRABTI

Forward yield	928.51% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	11.3%
Portfolio after 10y	$9.224768444729638e+22M	$37.7K ✓
Annual income after 10y	$92,228,602,655,528,430,000,000,000,000.00 ✓	$2,786.64
Total dividends collected	$9.22464356544689e+22M	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Buy	Buy

Year-by-year: KTRA vs BTI ($10,000, DRIP)

Year	KTRA Portfolio	KTRA Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$196,401	$185,701.02	$11,299	$598.92	+$185.1K → KTRA
2	$7,027,321	$6,817,172.01	$12,794	$703.91	+$7.01M → KTRA
3	$463,447,509	$455,928,275.47	$14,518	$829.07	+$463.43M → KTRA
4	$56,698,112,446	$56,202,223,611.72	$16,513	$978.64	+$56698.10M → KTRA
5	$12,912,579,631,755	$12,851,912,651,437.11	$18,827	$1,157.84	+$12912579.61M → KTRA
6	$5,484,711,654,366,623	$5,470,895,194,160,645.00	$21,518	$1,373.12	+$5484711654.35M → KTRA
7	$4,349,424,397,994,440,700	$4,343,555,756,524,268,500.00	$24,657	$1,632.46	+$4349424397994.42M → KTRA
8	$6,442,930,094,194,810,000,000	$6,438,276,210,088,955,000,000.00	$28,329	$1,945.74	+$6442930094194810.00M → KTRA
9	$17,833,450,250,405,050,000,000,000	$17,826,556,315,204,260,000,000,000.00	$32,637	$2,325.33	+$17833450250405050368.00M → KTRA
10	$92,247,684,447,296,380,000,000,000,000	$92,228,602,655,528,430,000,000,000,000.00	$37,708	$2,786.64	+$9.224768444729638e+22M → KTRA

KTRA vs BTI: Complete Analysis 2026

KTRA — Stock

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.

Full KTRA Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this KTRA vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KTRA vs SCHD KTRA vs JEPI KTRA vs O KTRA vs KO KTRA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.